Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

homeHome
play_circleCurrent Issuecheck_circleAccepted ManuscriptslistAll Issuesformat_indent_increaseIn Press ArticlessearchSearch
helpInstructions
infoJournal InformationgroupsBoards and committeesshareIndexing and Listing Sourcesshow_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Malpractice Statementmenu_bookReviewer and AE Registration FormemailSupportphoneContact Us
format_list_bulletedAPC
Authors GuideSubmit Manuscript

Crossref

1. Telaprevir/peginterferon-α-2a/ribavirin
2. A Real-Life Study of New Antiviral Therapies in a High Prevalence Geographical Area for Hepatitis C Virus Infection

- Alessandro Federico

- Marcello Dallio

- Giuseppe Gerardo Caprio

- Ilario de Sio

- Gaetano Cotticelli

- Pasquale Esposito

- Carmelina Loguercio

3.
4.
5. Comparison of peg-interferon, ribavirin plus telaprevirvssimeprevir by propensity score matching

- Hideki Fujii